Anti-angiogenesis in cancer therapy: Hercules and hydra
- 1 September 2013
- journal article
- review article
- Published by Elsevier BV in Cancer Letters
- Vol. 338 (2), 219-228
- https://doi.org/10.1016/j.canlet.2013.05.015
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancerCancer, 2011
- Sequential Sorafenib and Sunitinib for Renal Cell CarcinomaJournal of Urology, 2009
- The Role of Vascular Endothelial Growth Factor in Wound HealingJournal of Surgical Research, 2009
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- A role for VEGF as a negative regulator of pericyte function and vessel maturationNature, 2008
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Angiogenesis in life, disease and medicineNature, 2005
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996